![Matthew Harris](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 28 M $ al 31/07/2026
Matthew Harris is the founder and the Chief Scientific Officer of Clarity Pharmaceuticals Ltd., a company founded in 2010.
He was previously the Chief Executive Officer of Gateway Capital Ltd. and a Non-Executive Director at Genera Biosystems Ltd. from 2007 to 2008.
Dr. Harris holds a doctorate from The Australian National University and an MBA from the Australian Graduate School of Management.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 22/08/2025 | 16.699.842 ( 4,48 % ) | 28 M $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CLARITY PHARMACEUTICALS LTD | Fundador | 01/01/2010 |
| Empresas | Cargo | Fin |
|---|---|---|
| GENERA BIOSYSTEMS LIMITED | Director/Miembro de la Junta | 12/12/2008 |
Gateway Capital Ltd.
 Gateway Capital Ltd. Financial ConglomeratesFinance Investment firm | Presidente | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Australian National University
 Australian National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gateway Capital Ltd.
Gateway Capital Ltd. Financial ConglomeratesFinance Investment firm | Finance |
Genera Biosystems Ltd.
 Genera Biosystems Ltd. Medical SpecialtiesHealth Technology Manufactures, develops and commercializes multiplexed molecular diagnostic tests | Health Technology |
Australian Graduate School of Management
 Australian Graduate School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clarity Pharmaceuticals Ltd.
 Clarity Pharmaceuticals Ltd. Medical SpecialtiesHealth Technology Develops radiopharmaceutical products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
